Medigap Plan E is a Medicare Supplement plan that has not been sold to new subscribers since 2010. Here's what to expect if you're still using Plan E.

The plan will see Galapagos' 10-year, $5.1 billion R&D alliance with Gilead Sciences – first signed in 2019 and billed at the time as a groundbreaking new partnering model – significantly ...

Investors looking for a quick turnaround in the fortunes of Bayer are likely to be disappointed by chief executive Bill Anderson's assessment of the next couple of years as he delivers the group's ...